AI watches over ICU patients to detect pain and confusion

NCT ID NCT05127265

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether cameras, motion sensors, and other monitors can automatically detect signs of pain, delirium, and physical decline in critically ill patients. Researchers will collect video, movement, noise, light, and vital sign data from 400 adults in the ICU. The goal is to train artificial intelligence to recognize these conditions more consistently than busy nurses can. If it works, the system could alert staff to problems earlier and improve patient care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to an AI system that automatically detects pain, delirium, and physical decline in ICU patients, helping doctors intervene earlier.
What could go wrong
This is an early-stage observational study focused on developing algorithms, not testing a treatment. The AI may not be accurate enough for real-world use, and privacy concerns around continuous video monitoring exist.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONFUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Confusion Critical Illness delirium Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Florida Health Shands Hospital

    RECRUITING

    Gainesville, Florida, 32610, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.